Zomedica Corp. Quarterly Amortization of Intangible Assets in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Zomedica Corp. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2017 to Q2 2024.
  • Zomedica Corp. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $1.63M, a 25.8% increase year-over-year.
  • Zomedica Corp. annual Amortization of Intangible Assets for 2023 was $5.47M, a 51.2% increase from 2022.
  • Zomedica Corp. annual Amortization of Intangible Assets for 2022 was $3.62M, a 314% increase from 2021.
  • Zomedica Corp. annual Amortization of Intangible Assets for 2021 was $874K, a 290% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.63M +$333K +25.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.6M +$398K +33.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q2 2023 $4.61M $1.29M +$534K +70.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $4.08M $1.2M +$462K +62.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.62M $1.08M +$337K +45.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $3.28M $1.05M +$998K +2123% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.28M $759K +$714K +1587% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.57M $737K +$693K +1575% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $874K $738K +$649K +732% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $225K $47K +$1.6K +3.53% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $223K $45K +$10.00 +0.02% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $223K $44K -$1.04K -2.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $224K $88.7K +$88.4K +32503% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $136K $45.4K +$45.1K +16530% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $90.6K $45K +$44.7K +16563% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $45.9K $45K +$44.8K +16767% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $1.08K $272 -$1 -0.37% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $1.08K $273 -$158 -36.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.24K $270 -$423 -61% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $267 -$419 -61.1% Mar 31, 2019 10-Q 2019-05-10
Q1 2019 $1.66K $267 -$419 -61.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $2.08K $273 -$426 -60.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $2.51K $431 -$268 -38.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.78K $693 -$7 -1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.78K $686 -$13 -1.86% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.8K $699 Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 $699 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $700 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $699 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.